Related Experiment Videos
Serum lipoprotein measurement--liquid chromatography and sequential floatation (ultracentrifugation) compared
Clinical Chemistry
|May 1, 1983
Summary
This study introduces an HPLC method for serum lipoprotein analysis, showing good correlation with ultracentrifugal methods in normal and hyperlipidemic individuals. It also highlights lipoprotein size heterogeneity in liver disease and LCAT deficiency.
Area of Science:
- Clinical Chemistry
- Biochemistry
- Analytical Chemistry
Background:
- Serum lipoproteins are crucial biomarkers for cardiovascular health.
- Traditional methods for lipoprotein analysis can be complex and time-consuming.
- A need exists for efficient and accurate lipoprotein profiling.
Purpose of the Study:
- To evaluate a novel High-Performance Liquid Chromatography (HPLC) method for serum lipoprotein analysis.
- To compare the HPLC method with a sequential ultracentrifugal flotation technique.
- To investigate lipoprotein profiles in normal individuals, hyperlipidemia, liver diseases, and familial LCAT deficiency.
Main Methods:
- Development and application of an HPLC method for serum lipoprotein evaluation.
- On-line monitoring of cholesterol or phospholipids during HPLC analysis.
- Comparison of HPLC results with ultracentrifugal measurements in diverse patient groups.
Main Results:
- HPLC successfully resolved five distinct lipoprotein fractions based on particle size.
- Good correlation was observed between HPLC fractions and low-density lipoprotein (LDL), high-density lipoprotein 2 (HDL2), and high-density lipoprotein 3 (HDL3) in normal and hyperlipidemic subjects.
- Poorer correlations and characteristic heterogeneity in LDL and HDL2 particle sizes were noted in patients with liver diseases or familial LCAT deficiency.
Conclusions:
- The developed HPLC method provides a reliable and efficient alternative for serum lipoprotein analysis.
- The HPLC method effectively differentiates lipoprotein profiles in various clinical conditions.
- Observed heterogeneity in lipoprotein particle size may indicate underlying metabolic disturbances in liver disease and LCAT deficiency.